MAPT and Alzheimer disease: For instance, in moving Alzheimer’s disease research to a biological definition of AD, neuroimaging is recommended as one of the biomarkers that can serve as a proxy for the neuropathology of AD (along with amyloid deposition and neurofibrillary tau tangles).19